Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Depo-SubQ Provera 104 (Medroxyprogesterone Acetate) Injectable Suspension
Company:  Pfizer, Inc.
Application No.:  021584
Approval Date: 10/18/2004


Date created: December 012005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.